Quality of life and physical functioning in black and white adults with hypertrophic cardiomyopathy

Milla Arabadjian1, Gary Yu1, Allison Vorderstrasse2

  • 1New York University Rory Meyers College of Nursing, New York, NY, United States.

Insights

Black adults with hypertrophic cardiomyopathy (HCM) reported worse quality of life (QOL) and lower age-adjusted exercise capacity compared to White adults. Further research is needed to understand well-being in diverse HCM populations.

Area of Science:

  • Cardiology
  • Genetics
  • Public Health

Background:

  • Hypertrophic cardiomyopathy (HCM) is a common inherited cardiac disease with varied clinical presentations.
  • Quality of life (QOL) and physical functioning are critical aspects of HCM management but are understudied in diverse racial groups.

Purpose of the Study:

  • To investigate predictors of QOL and physical functioning in Black and White adults diagnosed with HCM.
  • To compare QOL and physical functioning between Black and White individuals with HCM.

Main Methods:

  • Analysis of a sub-sample from a prospective longitudinal HCM study.
  • Inclusion criteria: self-identified Black and White adults (≥18 years) with clinical HCM.
  • QOL assessed using the Minnesota Living with Heart Failure Questionnaire (MLWHF); physical functioning evaluated by exercise capacity (METs) and NYHA class.

Main Results:

  • The Black cohort reported significantly worse QOL (higher MLWHF scores) than the White cohort (p=0.042).
  • While mean exercise capacity was similar, the Black cohort exhibited a trend towards lower age-adjusted exercise capacity.
  • Female gender was consistently associated with poorer QOL and physical functioning across all participants.

Conclusions:

  • This study highlights disparities in QOL and physical functioning for Black individuals with HCM.
  • Emphasizes the necessity for comprehensive research into the well-being and functional status of Black populations affected by HCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
43
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
20
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
28
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
27
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31